Last reviewed · How we verify
Cetuximab, irinotecan
Cetuximab, irinotecan is a Small molecule drug developed by Asan Medical Center. It is currently in Phase 2 development. Also known as: PharmDx kit for EGFR staining..
At a glance
| Generic name | Cetuximab, irinotecan |
|---|---|
| Also known as | PharmDx kit for EGFR staining. |
| Sponsor | Asan Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial (PHASE3)
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer (PHASE3)
- A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer (PHASE2)
- A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors (PHASE1)
- EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer (EARLY_PHASE1)
- Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) (PHASE3)
- Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer (PHASE1)
- A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cetuximab, irinotecan CI brief — competitive landscape report
- Cetuximab, irinotecan updates RSS · CI watch RSS
- Asan Medical Center portfolio CI
Frequently asked questions about Cetuximab, irinotecan
What is Cetuximab, irinotecan?
Cetuximab, irinotecan is a Small molecule drug developed by Asan Medical Center.
Who makes Cetuximab, irinotecan?
Cetuximab, irinotecan is developed by Asan Medical Center (see full Asan Medical Center pipeline at /company/asan-medical-center).
Is Cetuximab, irinotecan also known as anything else?
Cetuximab, irinotecan is also known as PharmDx kit for EGFR staining..
What development phase is Cetuximab, irinotecan in?
Cetuximab, irinotecan is in Phase 2.
Related
- Manufacturer: Asan Medical Center — full pipeline
- Also known as: PharmDx kit for EGFR staining.
- Compare: Cetuximab, irinotecan vs similar drugs
- Pricing: Cetuximab, irinotecan cost, discount & access